DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsLowNeutral
Announced Sat, 23 May · 18:34 IST

Divi's Laboratories Limited has informed the Exchange about link of Q4FY2026 earnings call audio recording.

Investor Communications View source PDF

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.3%1-day move
₹6900.00
prior close
₹6750.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1+1.4+1.1+2.0-2.3-1.6-3.2-5.0-5.7-4.6-2.5-2.9+7.8
Up moveDown movePending
AI summary

Divi's Laboratories has disclosed the availability of the audio recording from its Q4 FY26 earnings conference call held on May 23, 2026 at 14:30 IST. The call covered results for the quarter and year ended March 31, 2026. The recording has been uploaded to the company's investor relations section on its website. This filing complies with SEBI's Regulation 30 (LODR) and provides a web link for investors to access the call. The filing itself is administrative in nature and does not include any substantive financial details, guidance, or strategic commentary.

Likely market impact

This is a routine compliance filing providing investors access to the earnings call recording. It does not contain new financial information or material disclosures that would directly impact the stock.